HF/Transplantation

Top Story

Low-dose colchicine cost-effective in COLCOT trial, over lifetime

Low-dose colchicine cost-effective in COLCOT trial, over lifetime
March 28, 2020
Meeting NewsPerspective

VICTORIA: Vericiguat reduces events in high-risk HF

March 28, 2020
Vericiguat, a novel oral soluble guanylate cyclase stimulator, reduced the incidence of HF hospitalization or CV death compared with placebo in patients with high-risk…
Meeting News

ACC goes virtual to present cardiovascular science, education

March 27, 2020
From March 28 to 30, the American College of Cardiology will host its Scientific Session, together with the World Congress of Cardiology, in a virtual format, with…
In the Journals

Myocardial injury may be key in predicting COVID-19 fatalities

March 27, 2020
New data from Wuhan, China, indicate that myocardial injury appears to be associated with death in patients with COVID-19. However, the association may not be as strong…
More Headlines »